SunSirs: With the 3-Pronged Approach, Big Bull Market of Chinese Herbal Medicines can Continue to be

　　The Chinese herbal medicine index on November 6 was 1334 points, a record high in the cycle, an increase of 36.82% from the lowest point of 975 points on November 25, 2019. (Note: Period refers to 2019-06-30 till now)In the 44th week of 2021 (11.1-11.5), there are 1 commodity that has risen in the price increase and decrease list of Chinese medicinal materials, 1 commodity that has fallen, and 6 commodities that have no rise or fall. The main commodities that rose were: Ophiopogon japonicus (2.26%); the main commodities that fell were: Panax notoginseng (-1.05%). The average increase and decrease this week was 0.15%.1. Chinese herbal medicine market last weekOphiopogon japonicus: Recently, the market has continued to sell smoothly, and the transaction price has risen slightly. The source of goods is relatively concentrated, and the source of retail is less. It is relatively reluctant to sell. The current transaction price of medium-quality goods is 67-70 yuan, and the transaction price of medium- and upper-quality goods is at 72-73 yuan, the transaction price of low-medium quality products is 63-65 yuan, the transaction price of special high-quality products is about 75 yuan, the transaction price of second-class goods from the origin is 63-64 yuan, and the transaction price of third and fourth-grade millet is 56-57 yuan. .The origin of Ophiopogon japonicus is moving smoothly, and the market is in a steady upward trend. Although the Bozhou market is not moving as much as the origin, the market has risen accordingly. Pharmaceutical products are between 65-68 yuan and first-class products are between 70-75 yuan; Shandong Haotonghuo 45 Around yuan.Panax notoginseng: The production of Panax notoginseng in Wenshan City, Wenshan Prefecture, Yunnan Province has continued. Recently, a large number of new products have been launched. Merchants mainly purchase according to normal demand. The market is operating stably. The price of new dry goods 120 is between 112-115 yuan. The price of 65 heads is 131-135 yuan, and the cut is 180-185 yuan. The price of raw goods varies from 30-35 yuan.The popularity of Yunnan Panax notoginseng is low, and a large number of new products will be launched in about half a month. Due to the current high tide of new products and the unsatisfactory market, the current market stock is still abundant, and merchants wait and see more. Now 80 pieces are priced at 125 Yuan, about 170 Yuan for 40 heads.Angelica sinensis: Affected by the epidemic, in the last two episodes, the quantity of angelica in the city has decreased significantly, the quantity of dried products is small, and the quantity of fresh angelica and fresh astragalus is stable. The epidemic has caused roads to be blocked. At present, the supply of goods on the market is all local goods. The supply of goods in neighboring counties is sporadic. There are few foreign merchants. This has led to the lack of purchase and sales in the market of origin, and the volume of goods and transactions are not as good as in previous years.The flow of people in the market is not large, and the common local processing households purchase small angelica products, suitable sources of goods are small, and the transaction volume is average. The overall purchase and sales of Angelica sinensis were weak, and the transaction price was firm. The transaction price of angelica pharmaceutical factory goods is 35-36.5 yuan/kg; the transaction price of angelica small strips is 36.5-37.5 yuan/kg, the transaction price of angelica middle strips is 38-40 yuan/kg; the transaction price of angelica large strips (good bars) At 41-43 yuan/kg.Codonopsis: In Yulin Pharmaceutical City, the price of Codonopsis pilosula (dangshen handle strips) is 55 yuan/kg, the price of (zhong strips) is 60 yuan/kg, and the price of (large strips) is 65 yuan/kg. The trend is smooth and the supply is not abundant. Dangshen is newly produced, and the price has risen due to various reasons such as reduced production.The fresh Codonopsis trade has gradually come to an end. The goods are small and the flow of people in the market is basically stable. Local processing households choose suitable sources to purchase. The overall transaction was stable, the owner of the consignor sold along, and the transaction price was basically stable. The transaction price of small bars is 5-6 yuan/city jin; middle bars 6.5-7 yuan/city jin; unified goods 6.5-7.5 yuan/city jin, large bars 7.5-9 yuan/city jin; extra-large bars 9.5 yuan/city jin and above.Astragalus: The market for dried Astragalus is low, and there are processing households who want the goods, and the supply of goods is small. Good products are hard to find. The transaction was deserted, and the transaction price was stable but hard. Astragalus section of 0.6-0.8cm size 29-32 yuan/kg, Astragalus section of 0.8-1.0cm size 35-38 yuan/kg; Astragalus section of 1.0-1.2cm size 40-44 yuan/kg; Astragalus section of 1.2-1.4cm size 44 -53 yuan/kg; the transaction price of the pharmaceutical factory’s feeding specifications of Maoqi is about 13-14 yuan/kg, the transaction price of Xiaomaoqi is about 11.5-13 yuan/kg; the transaction price of net stilbene is about 17-20 yuan/kg; Jingqi is about 20-23 yuan/kg; Maoertiao’s transaction price is about 8-9 yuan/kg; Jingertiao’s transaction price is about 11-12.5 yuan/kg.The overall transaction of fresh astragalus products was smooth, and the transaction price was basically stable. The transaction price of small strips is mostly 3-3.3 yuan/shijin; general goods 3.4-3.6 yuan/shijin; large strips are around 3.7-4 yuan/shijin, mainly depending on the skin color, size, and yield rate of the goods to discuss the price. The transaction price this year is about 0.3 yuan/shijin lower than last year.Honeysuckle: Honeysuckle has increased in recent days, and the market fluctuates little temporarily. The price of Hebei inspection package is 165 yuan, and the package price is 145 yuan; Shandong package inspection is 155-160 yuan, and the package inspection is about 140 yuan. The future trend is a concern.Honeysuckle in Pingyi County, Linyi City, Shandong Province has moved slowly recently, and the price has not changed. The current premium grade is 145 yuan/kg, the first grade is about 135 yuan, the second grade is about 125 yuan, and the third grade is about 115 yuan.Forsythia: Forsythia suspensa has been purchased and sold normally in the near future, and the market has remained stable from the previous period. The general price of boiled forsythia in Shanxi is now 95 yuan, and the price of qualified volatile oil is 115 yuan.Forsythia, high-priced merchants have not purchased a lot of goods recently. The supply of goods in the Yulin market is average, and the market is running steadily. The current price of boiled goods in Qingqiao is between 105-110 yuan, and the market will be flat after high prices. Lycium berries: Lycium berries are commercially available from time to time in recent days. The supply is okay, but the fluctuations in the market are limited. At present, the price of 280 pieces of goods in Ningxia in Bozhou market is mostly at 52-53 yuan, and the price of 380 pieces is offered at 46-48 yuan.2. Market review and outlook1. Judging from the first week of November, the number of rising varieties far exceeds the number of falling varieties, and the increase rate far exceeds the decrease rate. In the market, Rehmannia glutinosa, Salvia miltiorrhiza, Atractylodes macrocephala, Jujube seed, Cornus officinalis, Cortex Moutan, imported vine Vitex, Anemarrhena, Ophiopogon japonicus, Astragalus complanatus, Radix Paeoniae Alba, Eclipta prostrata, Chinese Chive Seed, and impatient are more concerned. In the short term, there is no sign of the market going down. With the participation of the origin, market, and pharmaceutical companies, the big bull market for Chinese medicinal materials will continue for some time.2. The front-end market has skyrocketed, and expansion is inevitable. If the consumption of Chinese medicinal materials cannot be increased, the market outlook will inevitably fall. In 2020, the State Food and Drug Administration approved a total of 48 innovative drugs, and only 3 Chinese medicines, namely Lianhua Light Cough Tablets from Ling Pharmaceutical, Muscle and Bone Analgesic Gel from Kangyuan Pharmaceutical, and Sangzhi from Wuhe Boao Alkaloid tablets. Although the number is small, it is the year when the most new Chinese medicines have been approved in the past five years. How can listed Chinese medicine companies increase their R&D investment and how are the national policies supporting them? If Chinese medicine wants to be modernized, it still depends on modern technology.